Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 8
2003 7
2004 3
2005 8
2006 9
2007 8
2008 2
2009 5
2010 4
2011 6
2012 5
2013 5
2014 11
2015 7
2016 8
2017 7
2018 5
2019 10
2020 11
2021 5
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
HIV vaccines 1983-2003.
McMichael AJ, Hanke T. McMichael AJ, et al. Among authors: hanke t. Nat Med. 2003 Jul;9(7):874-80. doi: 10.1038/nm0703-874. Nat Med. 2003. PMID: 12835708 Review.
MVA as a vector for vaccines against HIV-1.
Im EJ, Hanke T. Im EJ, et al. Among authors: hanke t. Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S89-97. doi: 10.1586/14760584.3.4.s89. Expert Rev Vaccines. 2004. PMID: 15285708 Review.
Identification of novel HIV-1-derived HLA-E-binding peptides.
Hannoun Z, Lin Z, Brackenridge S, Kuse N, Akahoshi T, Borthwick N, McMichael A, Murakoshi H, Takiguchi M, Hanke T. Hannoun Z, et al. Among authors: hanke t. Immunol Lett. 2018 Oct;202:65-72. doi: 10.1016/j.imlet.2018.08.005. Epub 2018 Aug 30. Immunol Lett. 2018. PMID: 30172717 Free PMC article.
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Bailón L, Llano A, Cedeño S, Escribà T, Rosás-Umbert M, Parera M, Casadellà M, Lopez M, Pérez F, Oriol-Tordera B, Ruiz-Riol M, Coll J, Perez F, Rivero À, Leselbaum AR, McGowan I, Sengupta D, Wee EG, Hanke T, Paredes R, Alarcón-Soto Y, Clotet B, Noguera-Julian M, Brander C, Molto J, Mothe B; AELIX002 Study Group. Bailón L, et al. Among authors: hanke t. Nat Med. 2022 Dec;28(12):2611-2621. doi: 10.1038/s41591-022-02060-2. Epub 2022 Oct 27. Nat Med. 2022. PMID: 36302893 Clinical Trial.
Development of a DNA-MVA/HIVA vaccine for Kenya.
Hanke T, McMichael AJ, Mwau M, Wee EG, Ceberej I, Patel S, Sutton J, Tomlinson M, Samuel RV. Hanke T, et al. Vaccine. 2002 May 6;20(15):1995-8. doi: 10.1016/s0264-410x(02)00085-3. Vaccine. 2002. PMID: 11983261 Review.
139 results